FH
ABBV icon

FWG Holdings’s AbbVie ABBV Stock Holding History

FWG Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$810K Sell
3,122
-104
-3% -$22.4K 0.28% 61
2026
Q1 		$667K Sell
3,226
-20
-0.6% -$4.44K 0.25% 65
2025
Q4 		$724K Buy
3,246
+862
+36% +$196K 0.27% 66
2025
Q3 		$537K Buy
2,384
+128
+6% +$26.1K 0.23% 74
2025
Q2 		$445K Buy
2,256
+313
+16% +$58.2K 0.21% 81
2025
Q1 		$376K Buy
+1,943
New +$378K 0.19% 82
2023
Q1 		– Sell
-2,496
Closed -$403K – 86
2022
Q4 		$403K Sell
2,496
-7
-0.3% -$1.07K 0.28% 55
2022
Q3 		$336K Buy
2,503
+857
+52% +$123K 0.25% 56
2022
Q2 		$252K Buy
+1,646
New +$252K 0.22% 72

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FWG Holdings's ABBV Position: Q2 2026 in Review

FWG Holdings reduced its AbbVie (ABBV) stake by 3.2% in Q2 2026, selling an estimated $22.4K and leaving 3,122 shares worth $810K. The position accounts for 0.28% of the portfolio, ranked #61.

FWG Holdings first reported a position in ABBV in Q2 2022 and has held it in 9 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • FWG Holdings held 3,122 shares of AbbVie worth $810K as of Q2 2026.
  • FWG Holdings sold 104 AbbVie shares in Q2 2026, an estimated $22.4K.
  • AbbVie made up 0.28% of FWG Holdings's portfolio in Q2 2026, its #61 holding.
  • FWG Holdings first reported a position in AbbVie in Q2 2022 and has held it in 9 quarters since.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on FWG Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.